| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Wellcome Research Laboratories, Department of Molecular Sciences, Langley Court, South Eden Park Road, Beckenham, Kent BR3 3BS
and2 Centre for Applied Microbiology and Research, Division of Pathology, Porton Down, Salisbury, Wiltshire SP4 0JG, U.K.
The proviral genome of the 32H reisolate of simian immunodeficiency of macaques (SIVmac32H) has been cloned and sequenced. Including both long terminal repeats, it is 10277 base pairs in length and contains open reading frames for all known SIV genes (gag, pol, vif, vpx, vpr, tat, rev, env and nef). This is the first report of an infectious SIVmac molecular clone which contains no premature termination codons. Three molecular clones of SIVmac32H have been constructed differing in sequence only within their last 1.2 kb. Two of the molecular clones, SIVmac32H(pJ5) and SIVmac32H (pC8), differ in the nef coding region by an in-frame deletion of four amino acids in pC8 and two conservative amino acid changes; other nucleotide changes in the 3' LTR were not associated with known functionally critical motifs. The third clone, SIVmac32H(pB1), contains the last 1.2 kb of the SIVmac251 clone pBK28. The biological properties of virus produced after electroporation of these clones into C8166 cells has been assessed by infection of rhesus and cynomolgus macaques, time to seroconversion and by induction of cytopathic effects upon co-cultivation of infected rhesus peripheral blood lymphocytes with C8166 cells. The viruses obtained from these clones have identical growth kinetics in vitro but differ in their ability to persist in macaques. Macaques infected with pJ5 derived virus remain viraemic longer than macaques infected with pC8-derived virus. PCR analysis of circulating provirus indicates that the nef gene evolved over time in pJ5 virus-infected macaques, whereas late in infection in pC8 virus-infected macaques the nef gene remained invariant in sequence. These results support the observation that a nef deletion mutant of SIV mac239 lost its pathogenic potential and resulted in low-level viraemia when rhesus macaques were infected. Virus challenge pools for vaccine studies have been prepared for pJ5 using both human and monkey cell substrates and these stocks have been titrated both in vitro and in vivo. Virus has also been prepared from pC8 and titrated in vitro. This virus pool is being assessed as an attenuated live-virus vaccine in macaques. Since only virus originating from the SIVmac239 molecular clone is known to cause AIDS-like symptoms in rhesus macaques consistently, the SIVmac32H molecular clones should tell us more about which viral sequence features are important for the pathogenesis of AIDS.
Present address: Department of Health Canada, Laboratory Center for Disease Control, Bureau for HIV/AIDS, Ottawa, Ontario, Canada K1A 0L2.
Received 13 April 1993;
accepted 18 October 1993.
This article has been cited by other articles:
|
|
 |
|
  N. Berry, R. Stebbings, D. Ferguson, C. Ham, J. Alden, S. Brown, A. Jenkins, J. Lines, L. Duffy, L. Davis, et al. Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8) J. Gen. Virol., September 1, 2008; 89(9): 2240 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stebbings, N. Berry, H. Waldmann, P. Bird, G. Hale, J. Stott, D. North, R. Hull, J. Hall, J. Lines, et al. CD8+ Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus J. Virol., October 1, 2005; 79(19): 12264 - 12272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schindler, J. Munch, M. Brenner, C. Stahl-Hennig, J. Skowronski, and F. Kirchhoff Comprehensive Analysis of Nef Functions Selected in Simian Immunodeficiency Virus-Infected Macaques J. Virol., October 1, 2004; 78(19): 10588 - 10597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Sharpe, A. Cope, S. Dowall, N. Berry, C. Ham, J. L. Heeney, D. Hopkins, L. Easterbrook, M. Dennis, N. Almond, et al. Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope J. Gen. Virol., September 1, 2004; 85(9): 2591 - 2602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Makitalo, P. Lundholm, J. Hinkula, C. Nilsson, K. Karlen, A. Morner, G. Sutter, V. Erfle, J. L. Heeney, B. Wahren, et al. Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen J. Gen. Virol., August 1, 2004; 85(8): 2407 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. M. Negri, S. Baroncelli, S. Catone, A. Comini, Z. Michelini, M. T. Maggiorella, L. Sernicola, F. Crostarosa, R. Belli, M. G. Mancini, et al. Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge J. Gen. Virol., May 1, 2004; 85(5): 1191 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. U. Vogel, M. R. Reynolds, D. H. Fuller, K. Vielhuber, T. Shipley, J. T. Fuller, K. J. Kunstman, G. Sutter, M. L. Marthas, V. Erfle, et al. Multispecific Vaccine-Induced Mucosal Cytotoxic T Lymphocytes Reduce Acute-Phase Viral Replication but Fail in Long-Term Control of Simian Immunodeficiency Virus SIVmac239 J. Virol., December 15, 2003; 77(24): 13348 - 13360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Strappe, J. Greatorex, J. Thomas, P. Biswas, E. McCann, and A. M. L. Lever The packaging signal of simian immunodeficiency virus is upstream of the major splice donor at a distance from the RNA cap site similar to that of human immunodeficiency virus types 1 and 2 J. Gen. Virol., September 1, 2003; 84(9): 2423 - 2430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nakajima, P. Ionescu, Y. Sato, M. Hashimoto, T. Kuroita, H. Takahashi, H. Yoshikura, and T. Sata In Situ Hybridization AT-Tailing with Catalyzed Signal Amplification for Sensitive and Specific in Situ Detection of Human Immunodeficiency Virus-1 mRNA in Formalin-Fixed and Paraffin-Embedded Tissues Am. J. Pathol., February 1, 2003; 162(2): 381 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. U. Vogel, H. Horton, D. H. Fuller, D. K. Carter, K. Vielhuber, D. H. O'Connor, T. Shipley, J. Fuller, G. Sutter, V. Erfle, et al. Differences Between T Cell Epitopes Recognized After Immunization and After Infection J. Immunol., October 15, 2002; 169(8): 4511 - 4521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. U. Vogel, T. C. Friedrich, D. H. O'Connor, W. Rehrauer, E. J. Dodds, H. Hickman, W. Hildebrand, J. Sidney, A. Sette, A. Hughes, et al. Escape in One of Two Cytotoxic T-Lymphocyte Epitopes Bound by a High-Frequency Major Histocompatibility Complex Class I Molecule, Mamu-A*02: a Paradigm for Virus Evolution and Persistence? J. Virol., October 11, 2002; 76(22): 11623 - 11636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Horton, T. U. Vogel, D. K. Carter, K. Vielhuber, D. H. Fuller, T. Shipley, J. T. Fuller, K. J. Kunstman, G. Sutter, D. C. Montefiori, et al. Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 J. Virol., June 14, 2002; 76(14): 7187 - 7202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sharpe, N. Polyanskaya, M. Dennis, G. Sutter, T. Hanke, V. Erfle, V. Hirsch, and M. Cranage Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity J. Gen. Virol., September 1, 2001; 82(9): 2215 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Canto-Nogues, S. Jones, R. Sangster, P. Silvera, R. Hull, R. Cook, G. Hall, B. Walker, E. J. Stott, D. Hockley, et al. In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo J. Gen. Virol., September 1, 2001; 82(9): 2225 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Khatissian, V. Monceaux, M.-C. Cumont, M.-P. Kieny, A.-M. Aubertin, and B. Hurtrel Persistence of Pathogenic Challenge Virus in Macaques Protected by Simian Immunodeficiency Virus SIVmac{Delta}nef J. Virol., February 1, 2001; 75(3): 1507 - 1515. [Abstract] [Full Text]
|
|
|
|
|
|
P. N. Fultz, P. J. Vance, M. J. Endres, B. Tao, J. D. Dvorin, I. C. Davis, J. D. Lifson, D. C. Montefiori, M. Marsh, M. H. Malim, et al. In Vivo Attenuation of Simian Immunodeficiency Virus by Disruption of a Tyrosine-Dependent Sorting Signal in the Envelope Glycoprotein Cytoplasmic Tail J. Virol., January 1, 2001; 75(1): 278 - 291. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Edinger, M. Ahuja, T. Sung, K. C. Baxter, B. Haggarty, R. W. Doms, and J. A. Hoxie Characterization and Epitope Mapping of Neutralizing Monoclonal Antibodies Produced by Immunization with Oligomeric Simian Immunodeficiency Virus Envelope Protein J. Virol., September 1, 2000; 74(17): 7922 - 7935. [Abstract] [Full Text]
|
|
|
|
|
|
T. Swigut, A. J. Iafrate, J. Muench, F. Kirchhoff, and J. Skowronski Simian and Human Immunodeficiency Virus Nef Proteins Use Different Surfaces To Downregulate Class I Major Histocompatibility Complex Antigen Expression J. Virol., June 15, 2000; 74(12): 5691 - 5701. [Abstract] [Full Text]
|
|
|
|
|
|
I. Ourmanov, C. R. Brown, B. Moss, M. Carroll, L. Wyatt, L. Pletneva, S. Goldstein, D. Venzon, and V. M. Hirsch Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV J. Virol., March 15, 2000; 74(6): 2740 - 2751. [Abstract] [Full Text]
|
|
|
|
|
|
H. Akari, S. Arold, T. Fukumori, T. Okazaki, K. Strebel, and A. Adachi Nef-Induced Major Histocompatibility Complex Class I Down-Regulation Is Functionally Dissociated from Its Virion Incorporation, Enhancement of Viral Infectivity, and CD4 Down-Regulation J. Virol., March 15, 2000; 74(6): 2907 - 2912. [Abstract] [Full Text]
|
|
|
|
|
|
S. Hodge, J. de Rosayro, A. Glenn, I. C. Ojukwu, S. Dewhurst, H. M. McClure, N. Bischofberger, D. C. Anderson, S. A. Klumpp, and F. J. Novembre Postinoculation PMPA Treatment, but Not Preinoculation Immunomodulatory Therapy, Protects against Development of Acute Disease Induced by the Unique Simian Immunodeficiency Virus SIVsmmPBj J. Virol., October 1, 1999; 73(10): 8630 - 8639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Almond, A. Jenkins, S. Jones, C. Arnold, P. Silvera, K. Kent, K. H. G. Mills, and E. J. Stott The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus J. Gen. Virol., September 1, 1999; 80(9): 2375 - 2382. [Abstract] [Full Text]
|
|
|
|
|
|
S. Carl, A. J. Iafrate, J. Skowronski, C. Stahl-Hennig, and F. Kirchhoff Effect of the Attenuating Deletion and of Sequence Alterations Evolving In Vivo on Simian Immunodeficiency Virus C8-Nef Function J. Virol., April 1, 1999; 73(4): 2790 - 2797. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Zauli, D. Gibellini, P. Secchiero, H. Dutartre, D. Olive, S. Capitani, and Y. Collette Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway Blood, February 1, 1999; 93(3): 1000 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Langlois, R. C. Desrosiers, M. G. Lewis, V. N. KewalRamani, D. R. Littman, J. Y. Zhou, K. Manson, M. S. Wyand, D. P. Bolognesi, and D. C. Montefiori Neutralizing Antibodies in Sera from Macaques Immunized with Attenuated Simian Immunodeficiency Virus J. Virol., August 1, 1998; 72(8): 6950 - 6955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-N. Xu, G. R. Screaton, F. M. Gotch, T. Dong, R. Tan, N. Almond, B. Walker, R. Stebbings, K. Kent, S. Nagata, et al. Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus-infected Cells J. Exp. Med., July 7, 1997; 186(1): 7 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Beer, M. Baier, J. zur Megede, S. Norley, and R. Kurth Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo PNAS, April 15, 1997; 94(8): 4062 - 4067. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
